Meeting the Challenge of Diabetes in China: Prevalence, Trends, and Geographic Variances

This comprehensive study examines the prevalence, trends, and geographic variances of diabetes in China compared to the United States. With a focus on diabetes and prediabetes rates, the analysis spans over two decades, highlighting the significant burden of the disease in the Chinese population. The research delves into the top countries affected by diabetes, the undiagnosed cases globally, and the detection rates in different Chinese provinces. Insights from the study shed light on the urgent need for targeted interventions and personalized medication strategies to address the growing diabetes epidemic in China.

• Diabetes
• China
• Prevalence
• Trends
• Geographic Variances

udekk Follow

Uploaded on Sep 29, 2024 | 0 Views

Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

Presentation Transcript

1. MEETING THE CHALLENGE OF DIABETES IN CHINA Guilhem Fabre, Universit Paul Val ry Zhen Luo, New York University Victor Rodwin, New York University

2. TOP TEN COUNTRIES FOR DIABETES : China, India, USA, Brazil, Mexico Source: International Diabetes Atlas, 2017.

3. PREVALENCE OF DIABETES IN CHINA AND US China: Diabetes: 10.9% Prediabetes: 35.7% US: Diabetes 12-14% Prediabetes: 33.9% Limin Wang et al. 2017. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA. ;317(24):2515-2523 & US CDC

4. PREVALENCE OF DIABETES IN CHINA AND US Diabetes Prevalence in China: the trend over 20 years 12.0% 10.0% 8.0% 6.0% 4.0% 2.0% 0.0% 1980 2001 2008 2013 Source: Cheng Hu and Weiping Jia Diabetes in China : Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personnalized Medication , Diabetes 2018 : 67 : 3-11.

5. DIABETES & PREDIABETES AMONG CHINESE ADULTS, 2008-2013 Source: Hu, C., & Jia, W. (2018). Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes, 67(1), 3-11.

6. DIABETES PREVALENCE BY PROVINCE 2013 Source: Zhou, M., Astell-Burt, T., Bi, Y., Feng, X., Jiang, Y., Li, Y., . . . Wang, L. (2014). Geographical variation in diabetes prevalence and detection in China: multilevel spatial analysis of 98,058 adults. Diabetes care, DC_141100.

7. TOP TEN COUNTRIES FOR UNDIAGNOSED DIABETES , 2017 Source: International Diabetes Atlas, 2017.

8. DIABETES DETECTION AMONG CHINESE PROVINCES , 2013 Source: Zhou, M., Astell-Burt, T., Bi, Y., Feng, X., Jiang, Y., Li, Y., . . . Wang, L. (2014). Geographical variation in diabetes prevalence and detection in China: multilevel spatial analysis of 98,058 adults. Diabetes care, DC_141100.

9. OVERWEIGHT & OBESITY AMONG CHINESE ADULTS, 2000-2014 Source: Hu, C., & Jia, W. (2018). Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes, 67(1), 3-11.

10. CHILD OBESITY = 10 % between 7 and 12 years in SHANGHAI Jeanette Wang. Explosion in childhood China worst ever , expert says of new study findings . South China Morning Post, April 27th, 2016. obesity in

11. GENETIC & ENVIRONMENTAL FACTORS FOR TYPE 2 DIABETES Source: Hu, C., & Jia, W. (2018). Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes, 67(1), 3- 11.

12. HOW TO TACKLE THE CRISIS Upstream: National Demonstration Areas for Non-communicable Disease Prevention and Control. Downstream: Medical Partnership.

13. NATIONAL DEMONSTRATION AREA (NDA)S FRAMEWORK County-level administrative areas. 250 counties, 9.29% of the total number. Diabetes detection rate: 79.54% versus the 44% national rate. Directed improvisation . Central government: General framework. Local government: Specific solutions.

14. NATIONAL DEMONSTRATION AREA (NDA)S FRAMEWORK The should according to the framework before applying to become NDA. Once central finance will subsidize the county government further promote population health. county government evaluate itself accepted, the to

15. DIABETES CONTROL NDAs BY REGIONS Diabetes Control in NDAs of Different Regions. 100.00% 90.00% 80.00% 70.00% 60.00% 50.00% 40.00% 30.00% 20.00% 10.00% 0.00% Diabetes Prevalence Treatment Control Standarized Control East Middle West Source: Jin, R., Li, J., Zhang, J., Li, J., Bian, F., Deng, G., . . . Jiang, Y. (2018). Management programs on diabetes among Chinese adults in the National Demonstration Areas for Comprehensive Prevention and Control of Non-communicable Diseases Chinese Journal of Epidemiology, 39(4), 407-411.

16. ADDRESSING BOTTLENECKS IN THE HOSPITAL SYSTEM: STATUS QUO Meng Roadmap healthy integrating delivery of medical care p.19-27, in Matthis Tepan & Jane (Editors), Serve the people : Innovation and IT in China s social devlopment agenda, Institute for China Studies, Papers on China, October 2018. Qingyue, to China a : the Ducket Mercator No 6,

17. PLAN TO REDUCE BOTTLENECKS, 2018 Meng Roadmap healthy integrating delivery of medical care p.19-27, in Matthis Tepan & Jane (Editors), Serve the people : Innovation and IT in China s social devlopment agenda, Institute for China Studies, Papers on China, October 2018. Qingyue, to China a : the Ducket Mercator No 6,

18. HEALTH WORKFORCE Source The Challenge of Non-communicable Diseases (NCDs) in China Government Responses and Opportunities for Reform. Tsung-Mei Cheng China s Healthcare System and Reform. Lawton R. Burns and Gordon G. Liu

19. HEALTH WORKFORCE Doctors in China: improving quality through modernisation of residency education. Jiming Zhu, Wenkai Li, Lincoln Chen. Lancet, June 2016 China s Physician and Nurse Workforce. Lawton Robert Burns

20. MEDICAL PARTNERSHIP Integrate community clinics and big central hospitals. Not only patients, but also physicians, can move upward or downward in this system. Beijing and Shanghai. Conflicts of interest.

21. MEDICAL PARTNERSHIP Community Clinics and Hospitals Source: Prof. Jia Weiping s presentation on the 2016 China-Japan Endocrine and Metabolic Diseases Forum (2016 ). Zheng Min: Prof. Jia Weiping: Diabetes Control and Shanghai s Hierarchical Medical System Model. https://www.cn-healthcare.com/article/20161024/content- 486605.html

22. PROBLEMS Physicians are unwilling to move downward. Patients preferences are hard to change. Brain drain . Chaoyang Hospital s experience: 2796 patients were transferred down to community clinics, while only 197 patients were referred up to the central hospital.

23. RECENT & FUTURE INNOVATIONS TO HELP PEOPLE LIVING WITH DIABETES G .Fagherazzi, P. Ravaud, Digital Diabetes : Perspectives for diabetes prevention, management and research , Diabetes Metab (2018) : https://www.scienc edirect.com/science /article/pii/S12623 6361830171X?via% 3Dihub

24. I.T & AI IN DIABETES RESEARCH, PREVENTION & MANAGEMENT G .Fagherazzi, P. Ravaud, Digital Diabetes : Perspectives for diabetes prevention, management and research , Diabetes Metab (2018) : https://www.scienced irect.com/science/arti cle/pii/S1262363618 30171X?via%3Dihu b